Depreciation of BRAINSTORM CELL THERAPEUTICS INC. from 31 Dec 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
BRAINSTORM CELL THERAPEUTICS INC. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2011 to 30 Sep 2025.
  • BRAINSTORM CELL THERAPEUTICS INC. Depreciation for the quarter ending 30 Sep 2025 was $48,000, a 19% decline year-over-year.
  • BRAINSTORM CELL THERAPEUTICS INC. Depreciation for the twelve months ending 30 Sep 2025 was $204,000, a 19% decline year-over-year.
  • BRAINSTORM CELL THERAPEUTICS INC. annual Depreciation for 2024 was $240,000, a 9.4% decline from 2023.
  • BRAINSTORM CELL THERAPEUTICS INC. annual Depreciation for 2023 was $265,000, a 7% decline from 2022.
  • BRAINSTORM CELL THERAPEUTICS INC. annual Depreciation for 2022 was $285,000, a 9.6% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

BRAINSTORM CELL THERAPEUTICS INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $204,000 $48,000 -$11,000 -19% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $215,000 $51,000 -$13,000 -20% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $228,000 $52,000 -$12,000 -19% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $240,000 $53,000 -$13,000 -20% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $253,000 $59,000 -$6,000 -9.2% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $259,000 $64,000 -$3,000 -4.5% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $262,000 $64,000 -$3,000 -4.5% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $265,000 $66,000 -$4,000 -5.7% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $269,000 $65,000 -$5,000 -7.1% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $274,000 $67,000 -$4,000 -5.6% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $278,000 $67,000 -$7,000 -9.5% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $285,000 $70,000 $0 0% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $285,000 $70,000 +$3,000 +4.5% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $282,000 $71,000 +$9,000 +15% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $273,000 $74,000 +$13,000 +21% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $260,000 $70,000 +$6,000 +9.4% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $254,000 $67,000 +$11,000 +20% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $243,000 $62,000 +$12,000 +24% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $231,000 $61,000 +$12,000 +24% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $219,000 $64,000 +$14,000 +28% 01 Oct 2020 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 $205,000 $56,000 +$19,000 +51% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $186,000 $50,000 +$17,000 +52% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $169,000 $49,000 +$5,000 +11% 01 Jan 2020 31 Mar 2020 10-Q 26 Apr 2021 2021 Q1
Q4 2019 $164,000 $50,000 +$29,000 +138% 01 Oct 2019 31 Dec 2019 10-K 04 Feb 2021 2020 FY
Q3 2019 $135,000 $37,000 +$4,000 +12% 01 Jul 2019 30 Sep 2019 10-Q 15 Oct 2020 2020 Q3
Q2 2019 $131,000 $33,000 +$2,000 +6.5% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 $129,000 $44,000 +$19,000 +76% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $110,000 $21,000 -$7,000 -25% 01 Oct 2018 31 Dec 2018 10-K 18 Feb 2020 2019 FY
Q3 2018 $117,000 $33,000 +$10,000 +43% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $107,000 $31,000 +$13,000 +72% 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2019 2019 Q2
Q1 2018 $94,000 $25,000 +$9,000 +56% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q4 2017 $85,000 $28,000 +$6,000 +27% 01 Oct 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 $79,000 $23,000 +$6,000 +35% 01 Jul 2017 30 Sep 2017 10-Q 29 Oct 2018 2018 Q3
Q2 2017 $73,000 $18,000 -$4,000 -18% 01 Apr 2017 30 Jun 2017 10-Q 23 Jul 2018 2018 Q2
Q1 2017 $77,000 $16,000 $0 0% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1
Q4 2016 $77,000 $22,000 01 Oct 2016 31 Dec 2016 10-K 08 Mar 2018 2017 FY
Q3 2016 $17,000 01 Jul 2016 30 Sep 2016 10-Q 17 Oct 2017 2017 Q3
Q2 2016 $22,000 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2
Q1 2016 $16,000 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1

BRAINSTORM CELL THERAPEUTICS INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $240,000 -$25,000 -9.4% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $265,000 -$20,000 -7% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $285,000 +$25,000 +9.6% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $260,000 +$41,000 +19% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $219,000 +$55,000 +34% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2022 2021 FY
2019 $164,000 +$54,000 +49% 01 Jan 2019 31 Dec 2019 10-K 04 Feb 2021 2020 FY
2018 $110,000 +$25,000 +29% 01 Jan 2018 31 Dec 2018 10-K 18 Feb 2020 2019 FY
2017 $85,000 +$8,000 +10% 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
2016 $77,000 -$10,000 -11% 01 Jan 2016 31 Dec 2016 10-K 08 Mar 2018 2017 FY
2015 $87,000 -$19,000 -18% 01 Jan 2015 31 Dec 2015 10-K 29 Mar 2017 2016 FY
2014 $106,000 +$9,000 +9.3% 01 Jan 2014 31 Dec 2014 10-K 09 Mar 2016 2015 FY
2013 $97,000 -$60,000 -38% 01 Jan 2013 31 Dec 2013 10-K 26 Mar 2015 2014 FY
2012 $157,000 +$4,000 +2.6% 01 Jan 2012 31 Dec 2012 10-K 27 Mar 2014 2013 FY
2011 $153,000 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.